Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-035929
Filing Date
2025-03-10
Accepted
2025-03-10 08:07:24
Documents
108
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K algs-20241231.htm   iXBRL 10-K 3338416
2 EX-4.3 algs-ex4_3.htm EX-4.3 87776
3 EX-10.18 algs-ex10_18.htm EX-10.18 263469
4 EX-10.19 algs-ex10_19.htm EX-10.19 167705
5 EX-10.20 algs-ex10_20.htm EX-10.20 42183
6 EX-19.1 algs-ex19_1.htm EX-19.1 66076
7 EX-23.1 algs-ex23_1.htm EX-23.1 11892
8 EX-31.1 algs-ex31_1.htm EX-31.1 17822
9 EX-31.2 algs-ex31_2.htm EX-31.2 17796
10 EX-32.1 algs-ex32_1.htm EX-32.1 11954
11 EX-32.2 algs-ex32_2.htm EX-32.2 12582
12 GRAPHIC img17594357_0.jpg GRAPHIC 142401
13 GRAPHIC img17594357_1.jpg GRAPHIC 392057
14 GRAPHIC img17594357_2.jpg GRAPHIC 268009
15 GRAPHIC img17594357_3.jpg GRAPHIC 336659
16 GRAPHIC img17594357_4.jpg GRAPHIC 95162
17 GRAPHIC img17594357_5.jpg GRAPHIC 258554
  Complete submission text file 0000950170-25-035929.txt   17752339

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT algs-20241231.xsd EX-101.SCH 1867857
111 EXTRACTED XBRL INSTANCE DOCUMENT algs-20241231_htm.xml XML 2257872
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39617 | Film No.: 25722214
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)